# Merck expands life science manufacturing in Wuxi, China with $110M investment

Merck signed an agreement to expand its Asia Pacific Mobius single-use manufacturing center in Wuxi National High-Tech District, China. The company plans to spend about $110 million over six years, creating about 1,000 new jobs by 2024.

- Type: Expansion
- Announced: 2022-04-28
- Where: Wuxi National High-Tech District, China
- Value: $110.0M
- Jobs: 1,000
- Starts operating: 2024
- Status: announced
- Products: biopharma single-use technical components
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Merck](https://endata.com/companies/1841.md)

## Sources

- [govt.chinadaily.com.cn](https://govt.chinadaily.com.cn/s/202204/28/WS628b0a0b498e6a12c122cc98/germanys-merck-expands-investment-in-life-science-in-wnd.html), 2022-04-28: "The new agreement underscores Merck's continued commitment to our customers in China and the fast-growing Asia-Pacific region."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.